Eton Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Eton Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q3 2024.
  • Eton Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.38M, a 0.17% decline year-over-year.
  • Eton Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.14M, a 25.6% decline from 2022.
  • Eton Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.22M, a 24.8% increase from 2021.
  • Eton Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.38M.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.38M -$4K -0.17% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q1 2024 $3.09M $821K -$51K -5.85% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $3.14M -$907K -$1.79M -202% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $4.93M $2.39M +$1.44M +152% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $3.49M $785K -$515K -39.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $4.01M $872K -$211K -19.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $4.22M $886K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $949K -$60K -5.95% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.3M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.08M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $1.01M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q4 2019 $1.89M $501K +$282K +129% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-05
Q3 2019 $1.61M $537K +$372K +225% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $1.23M $505K +$89K +21.4% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $1.15M $345K -$705K -67.1% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $1.85M $219K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 $165K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $416K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $1.05M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.